Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Health News
  • Elsevier launches...

Elsevier launches LeapSpace: AI-Assisted workspace set to transform scientific research

Written By : MD Bureau Published On 2025-11-21T17:30:59+05:30  |  Updated On 21 Nov 2025 5:31 PM IST
Elsevier launches LeapSpace: AI-Assisted workspace set to transform scientific research
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Elsevier, a global leader in advanced information and decision support in science and healthcare, introduces LeapSpace™, a next-generation AI-assisted workspace built to transform how academic and corporate scientists work. Designed for speed, collaboration, and discovery, LeapSpace empowers academic and corporate researchers to uncover deeper insights, accelerate innovation, and collaborate seamlessly - in one secure environment they can trust.

84% of researchers say they have used AI tools in their work, but only 22% trust existing tools. Designed with thousands of researchers, LeapSpace builds on the success of ScienceDirect AI and Scopus AI, bringing together the broadest collection of peer-reviewed scientific content and responsible AI. It includes innovative Trust Cards, a foundational capability which provides context and transparency into every result, supporting critical thinking and helping researchers calibrate the strength of the evidence.

“LeapSpace enables researchers to move from curiosity to discovery without leaving trusted ground,” said Judy Verses, President, Academic and Government, Elsevier. “By combining an unparalleled body of peer-reviewed research with responsible AI, we’re supporting the research community to build on the strongest foundations of trusted knowledge to advance human progress.”

A trusted foundation for scientific progress

Unlike general-purpose AI tools that typically rely on unverified web data, LeapSpace draws only from the world’s most trusted scientific content. It already includes the largest collection of research abstracts as well as millions of peer-reviewed full-text articles and books from Elsevier and other leading scientific publishers and societies, which will continually expand. Our vision is to enable researchers to build on the strongest foundations of trusted knowledge, harnessing the power of responsible AI, to advance progress.

A growing content set that already includes:

• The world's largest collection of research abstracts, as well as data and analytics, from Scopus, Elsevier’s publisher-neutral database of 100+ million records from 7,000+ global publishers.

• 15+ million peer-reviewed full-text articles and book content from Elsevier and other scientific publishers and societies.

An independent Advisory Board will oversee LeapSpace’s transparency, ensuring its algorithms remain explainable and publisher-neutral.

Purpose-Built for Researchers 

LeapSpace is designed specifically for researchers to help them carry out multiple tasks in one secure environment so they can achieve better outcomes, faster, with confidence.

Key features include:

• One seamless assistant: Generate ideas, plan projects, explore literature, find collaborators, and identify funding — all with a powerful AI that analyzes abstracts and full text to deliver structured, referenced answers. 

• Comprehensive trusted content: A certified and curated dataset of millions of peer-reviewed full text articles, books, and the world’s largest database of research abstracts from top academic publishers and societies.

• Trust Cards: Every AI-generated insight includes a ‘Trust Card’ designed to give researchers confidence to make informed decisions - showing sources, an explanation for why a source was cited, surfacing contradictions and helping researchers to calibrate the strength of the evidence.

• Deep Research: Agentic AI delivers detailed reports, highlights emerging patterns, assumptions and limitations, and evidence gaps.

• Upload your own content: Users can also upload their own material to enrich analysis. 

• Integrated funding discovery: Access 45,000 active and recurring grants worth over $100 billion, drawn from Elsevier’s Funding Institutional database. 

• Efficiency tools: Features such as Reading Assistant, Compare, and Author Search help researchers rapidly evaluate evidence and identify collaborators.

• Privacy and security: Built with enterprise-grade security, Elsevier ensures responsible AI use and data privacy in its AI solutions, in line with its Privacy Principles. 

Advanced AI, Grounded in Human Expertise 

LeapSpace combines agentic AI, generative AI, reasoning engines, and retrieval-augmented generation to support a wide range of research workflows — from literature analysis to hypothesis generation and data exploration.  Every feature reflects Elsevier’s Responsible AI Principles, emphasizing transparency, explainability, and human oversight. Researchers have full visibility into how results are generated. 

Developed with the Research Community

Thousands of researchers from 300+ institutions in 64 countries participated in the development and testing of LeapSpace. Early users report that it saves significant time, improves research design, uncovers missed insights and deepens analysis — becoming a daily starting point for key tasks across the researcher workflow.

Cara O’Neill MD, FAAP, Chief Science Officer, Cure Sanfilippo Foundation, said: “Rare disease research is limited by the small number of experts focused on each disease, Sanfilippo syndrome being no exception. We rely on connections and learnings across multiple disciplines to bridge gaps in direct evidence. Synthesizing vast amounts of often disparate information is a challenge. In my early experience with LeapSpace, I've been impressed with how it's able to address these challenges while providing confidence in the accuracy and rigor of its outputs.”

ElsevierLeapSpaceAI assisted workspaceartificial inteligence
MD Bureau
MD Bureau
    Show Full Article
    Next Story

    Editorial

    Effect of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II Hemorrhoids: the IMPACT HD Study

    Effect of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II...

    Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

    Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

    Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates

    Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates

    Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals

    Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals

    Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin

    Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin

    View All

    Journal Club Today

    Research uncovers new molecular and immune insights into recurrent miscarriage causes

    Research uncovers new molecular and immune insights into recurrent miscarriage causes

    View All

    Health News Today

    Health Bulletin 21/November/2025

    Health Bulletin 21/November/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok